Search results
Results From The WOW.Com Content Network
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc. Microbia was founded by postdocs from the lab of Gerald Fink at the Whitehead Institute to commercialize approaches that had been developed in the lab to improve industrial fermentation of fungi, to genetically engineer them to produce secondary metabolites more efficiently or to ...
Ironwood Pharmaceuticals Prices Public Offering of Common Stock CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NAS: IRWD) today announced the pricing of an underwritten public ...
Ironwood Pharmaceuticals Provides Fourth Quarter 2012 Investor Update Initiated Promotional Efforts for LINZESS™ (linaclotide) with Forest in December 2012; LINZESS Available to Patients in ...
Ironwood Pharmaceuticals Provides Third Quarter 2012 Investor Update - Received FDA Approval of LINZESS™ (linaclotide) for Treatment of Adult Patients with IBS-C or CIC; Prepared for Commercial ...
Ironwood Pharmaceuticals: MRP was spun off from Lennar and replaced IRWD which was no longer representative of the small-cap market space. [8] January 27, 2025: ARWR: Arrowhead Pharmaceuticals: B: Barnes Group: B was acquired by Apollo Global Management. ARWR was moved from the S&P 400 to replace it as it was more representative of the small ...
He has been on the Boards of Ironwood Pharmaceuticals [5] and Harley-Davidson. [6] Conrades was an executive producer of the 2013 documentary film 20 Feet from Stardom, [7] which won the 2014 Academy award for Best Documentary. [citation needed] He is a Fellow of the American Academy of Arts and Sciences. [8]
Ironwood Pharmaceuticals Announces Partial Exercise of Underwriters' Option in Public Offering of Common Stock CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NAS: IRWD) today ...
Small biotechnology companies typically risk everything for their first 15 years or so until their first big drugs win approval. Once sales start rolling in, it should be time to invest in the ...